In a patient receiving systemic steroids (e.g., prednisone ≥10–20 mg/day), how can I differentiate whether leukocytosis is due to infection or steroid effect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differentiating Infection from Steroid-Induced Leukocytosis

In patients receiving systemic steroids (≥10–20 mg/day prednisone), a left shift with >6% band forms and toxic granulation strongly suggests infection rather than steroid effect, as these features are rare in steroid-induced leukocytosis. 1

Expected Steroid-Induced Leukocytosis Patterns

Magnitude and Timing

  • Low-dose steroids (<20 mg prednisone): Mean increase of 0.3 × 10⁹/L WBCs 2
  • Medium-dose steroids (20–60 mg prednisone): Mean increase of 1.7 × 10⁹/L WBCs 2
  • High-dose steroids (>60 mg prednisone): Mean increase of 4.84 × 10⁹/L WBCs, peaking at 48 hours 2
  • Chronic steroid use: Average increase of 5 × 10⁹/L WBCs in patients with acute infections 3
  • WBC counts can exceed 20,000/mm³ as early as day 1, persisting throughout therapy 1
  • Maximal leukocytosis typically occurs within 2 weeks, then decreases but remains above baseline 1

Differential Cell Pattern (Steroid Effect)

  • Neutrophilia (polymorphonuclear predominance) 1, 4
  • Monocytosis 1
  • Eosinopenia 1, 4
  • Lymphopenia (particularly T-cells) 4
  • Absence of left shift (<6% bands) 1
  • Absence of toxic granulation 1

Key Discriminating Features Suggesting Infection

Critical Red Flags

  • Left shift >6% band forms - this is the single most reliable discriminator 1
  • Toxic granulation in neutrophils 1
  • WBC increase exceeding expected steroid effect:
    • Any increase after low-dose steroids suggests alternative cause 2
    • Increase >4.84 × 10⁹/L after high-dose steroids 2
    • Increase >5 × 10⁹/L in chronic steroid users 3

Clinical Context

  • Fever (though steroids may blunt fever response) 5
  • Hemodynamic instability (tachycardia, hypotension not explained by underlying condition) 6
  • New or worsening organ dysfunction 7
  • Respiratory symptoms with leukocytosis 7
  • Positive cultures or imaging findings consistent with infection 8

Practical Diagnostic Algorithm

Step 1: Review the Differential

  • Calculate band percentage: >6% bands strongly favors infection 1
  • Assess for toxic granulation: presence indicates infection 1
  • If either present → treat as infection

Step 2: Quantify Expected Steroid Effect

  • Determine steroid dose category (low/medium/high) 2
  • Calculate expected WBC increase based on dose 2
  • If WBC increase exceeds expected range → suspect infection

Step 3: Assess Temporal Pattern

  • Steroid effect peaks at 48 hours 2
  • Progressive rise beyond 48 hours or after initial plateau → suspect infection
  • New leukocytosis after stable period on steroids → infection until proven otherwise

Step 4: Evaluate Clinical Context

  • Screen for infection sources: respiratory (40% of infections in steroid users), urinary, skin/soft tissue 7
  • Consider fungal infections (Candida, Aspergillus) - more common with steroids than bacterial 9, 7
  • High-risk features: diabetes, immunocompromised state, combination immunosuppression 9, 7

Common Pitfalls to Avoid

Do Not Assume Steroid Effect When:

  • Patient on low-dose steroids (<20 mg/day) with any significant leukocytosis 2
  • Left shift or toxic granulation present 1
  • Eosinophilia develops (suggests allergic/parasitic process, not steroid effect) 10
  • Patient has baseline infection risk factors: diabetes, chronic immunosuppression, recent infection 9, 7

Critical Safety Considerations

  • Steroids mask infection symptoms - maintain high index of suspicion 7
  • Bacterial infections represent 90% of infectious episodes in steroid users 7
  • Respiratory infections account for 40% of infections during/after steroid treatment 7
  • Fungal superinfection risk increases with steroid dose ≥20 mg/day for ≥2 weeks 9
  • Infection during steroid therapy increases mortality independent of disease severity 7

When in Doubt

  • Obtain cultures (blood, urine, sputum as indicated) before attributing leukocytosis to steroids alone 8
  • Image potential infection sources if clinical suspicion exists 8
  • Consider empiric antibiotics in high-risk patients with unexplained leukocytosis, especially if hemodynamically unstable 7
  • Do not delay treatment for suspected infection while awaiting culture results in critically ill patients 7

References

Guideline

genetic testing in clinical settings.

American Journal of Kidney Diseases, 2018

Guideline

Corticosteroid Use and Bacterial Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Corticosteroid-Associated Yeast Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Leukocytosis: basics of clinical assessment.

American family physician, 2000

Related Questions

How to manage steroid-induced leukocytosis (elevated white blood cell count)?
What to do with an adult patient with leukocytosis (elevated white blood cell count) to 17,000 with neutrophilic predominance while on steroid (corticosteroid) therapy?
Can steroids induce leukopenia?
Can a steroid (corticosteroid) injection, such as triamcinolone (triamcinolone) or methylprednisolone (methylprednisolone), in the shoulder cause leukocytosis (elevated white blood cell count) in a patient with a history of shoulder pain or inflammation?
In a patient who received a single 50 mg dose of prednisone and recently underwent chemotherapy, with a leukocyte count of 11.5 ×10⁹/L, elevated C‑reactive protein, and low‑grade fever (37.5‑37.7 °C), is the leukocytosis likely a prednisone side effect or indicative of an underlying inflammatory or infectious process?
Can fluvoxamine be co‑prescribed with clonazepam safely, and what are the interaction risks?
In a standard basal‑bolus insulin regimen for an adult, how many times per day should bolus (prandial) insulin be administered?
Can fluvoxamine (SSRI) be safely combined with clonazepam (benzodiazepine), and what dosing and monitoring considerations are needed, especially in elderly patients or those with hepatic impairment?
Is an 8 mm lumbar disc extrusion on magnetic resonance imaging clinically significant?
What are the clinical signs and symptoms of diphtheria, and is there a mnemonic to remember them?
A patient presents with a gray, adherent pseudomembrane on the oropharynx; what is the diagnosis and what medications should be given?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.